tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Advertisement

Basilea Pharmaceutica (BSLN) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Basilea Pharmaceutica
CHF53.80
CHF655.08M
8.40
33.83%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF2.99
$120.72M
-48.80%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF2.93
CHF659.51M
22.59%
0 Buy
1 Hold
0 Sell
Hold
Newron Pharmaceuticals SpA
CHF6.79
CHF135.54M
9.62
-13.94%
0 Buy
0 Hold
0 Sell
Hold
Santhera Pharmaceuticals Holding
CHF14.00
CHF181.01M
2.58
49.89%
1 Buy
0 Hold
0 Sell
Moderate Buy
Kuros Biosciences
CHF28.58
$1.05B
139.77%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:BSLN
Basilea Pharmaceutica
53.80
13.60
33.83%
CH:MOLN
Molecular Partners AG
2.99
-2.85
-48.80%
CH:IDIA
Idorsia Ltd
2.93
0.54
22.59%
CH:NWRN
Newron Pharmaceuticals SpA
6.79
-1.10
-13.94%
CH:SANN
Santhera Pharmaceuticals Holding
14.00
4.63
49.41%
CH:KURN
Kuros Biosciences
28.58
16.66
139.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis